RUBICON Share Price Today - Rubicon Research on NSE/BSE

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,963.50	#1 4,71,109.42	39.39	#1 61,673.90	12.69	#1 11,565	26.53	57.67
Divis Laboratories	8,585.00	2,27,904.78	83.29	11,067.00	13.95	2,568	65.50	87.46
Torrent Pharmaceuticals	5,050.00	1,92,085.77	90.03	13,886.20	20.34	2,138	3.28	59.47
Cipla	1,474.40	1,19,108.71	35.46	29,044.60	2.24	3,870	-39.18	61.69
Zydus Life Science	1,121.00	1,12,798.83	21.93	27,657.90	17.64	5,026	7.82	50.99
Lupin	2,393.00	1,09,415.75	#1 20.61	29,038.90	#1 26.75	5,356	87.72	46.72
Mankind Pharma	2,483.00	1,02,546.90	49.34	14,636.40	14.85	1,938	29.13	46.36
Dr Reddys Laboratories	1,180.00	98,490.95	30.09	35,058.60	3.90	4,158	-69.10	39.90
Laurus Labs	1,811.40	97,789.62	90.00	6,867.80	22.01	890	#1 123.93	80.59
Aurobindo Pharma	1,554.70	89,454.00	26.19	33,384.70	3.21	3,376	1.99	51.68

Quarterly Financials	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026
Revenue	317	299	314	358	353	413	479	517
Expenses	257	234	244	286	273	318	367	395
EBITDA	61	64	70	73	80	95	112	121
Operating Profit %	19 %	21 %	22 %	20 %	22 %	23 %	23 %	23 %
Depreciation	9	8	9	10	10	12	12	12
Interest	10	7	8	12	11	11	10	10
Profit Before Tax	41	49	53	51	60	72	91	99
Tax	16	15	15	15	16	18	18	22
Net Profit	26	35	38	36	43	54	73	77
EPS in ₹	1.66	2.27	2.50	2.37	2.81	3.49	4.46	4.68

Balance Sheet	2020	2021	2022	2023	2024	2025	2026
Total Assets	430	538	560	750	1,110	1,451	2,327
Fixed Assets	157	188	193	199	307	327	519
Current Assets	265	340	328	502	763	1,063	1,682
Capital Work in Progress	2	6	3	25	10	7	41
Investments	19	14	0	0	0	0	729
Other Assets	252	331	364	526	793	1,118	0
Total Equity & Liabilities	430	538	560	750	1,110	1,451	2,327
Current Liabilities	78	111	184	361	573	786	836
Non Current Liabilities	12	53	71	102	152	124	202
Total Equity	341	374	305	286	385	541	1,289
Reserve & Surplus	335	369	300	281	370	526	1,272
Share Capital	5	5	5	5	15	15	17

Cash Flow	2020	2021	2022	2023	2024	2025
Net Cash Flow	1	67	-46	16	-4	54
Investing Activities	-84	-46	-46	-32	-68	-65
Operating Activities	6	62	-63	-75	21	159
Financing Activities	80	52	63	123	44	-40

% Holding	Jul 2024	Sept 2025	Oct 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	84.15 %	59.99 %	59.99 %	59.99 %	59.86 %	59.76 %
FIIs	0.00 %	9.37 %	9.37 %	7.99 %	7.54 %	7.52 %
DIIs	0.00 %	10.54 %	10.54 %	9.45 %	10.02 %	9.43 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	0.00 %	18.28 %	18.28 %	2.71 %	2.82 %	3.46 %
Others	15.85 %	1.82 %	1.82 %	19.86 %	19.76 %	19.84 %
No of Share Holders	15	1,05,311	1,05,311	31,914	33,738	43,254

Annual Cash Flows	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Dividend Per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.00
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
26 Aug 2026	Annual General Meeting	NA	26 Aug 2026	1,440.20	1,492.60
07 Aug 2026	Dividend	₹ 1.50 /share	07 Aug 2026	967.90	1,492.60
13 Nov 2025	Quarterly Result Announcement	NA	13 Nov 2025	638.50	627.25
03 Feb 2026	Quarterly Result Announcement	NA	03 Feb 2026	650.05	688.90
29 May 2026	Quarterly Result Announcement	NA	29 May 2026	969.10	967.90

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
Motilal Oswal Contra Fund Direct-Growth	0.00%	-7962	-0.30%	0.00%
TRUSTMF Mid Cap Fund Direct-Growth	0.84%	-6473	-0.21%	-0.14%
Bajaj Finserv Small Cap Fund Direct-Growth	4.18%	-1819	0.83%	0.81%
ICICI Prudential Long Term Wealth Enhancement Fund Direct-Growth	0.49%	1346	0.49%	0.49%
Motilal Oswal BSE 1000 Index Fund Direct-Growth	0.02%	95	0.02%	0.02%
Kotak Healthcare Fund Direct-Growth	2.07%	0	0.00%	0.27%
Kotak Midcap Fund Direct-Growth	0.78%	0	0.00%	0.20%
Bandhan Nifty Total Market Index Fund Direct-Growth	0.02%	0	0.00%	0.01%
Canara Robeco Manufacturing Fund Direct-Growth	2.65%	0	0.00%	0.37%
Edelweiss Recently Listed IPO Fund Direct-Growth	2.60%	0	0.00%	0.59%
Groww Nifty Total Market Index Fund Direct-Growth	0.02%	0	0.00%	0.01%
HDFC Business Cycle Fund Direct-Growth	0.00%	0	0.00%	0.00%
HDFC Innovation Fund Direct-Growth	2.50%	0	0.65%	0.68%
HDFC Pharma And Healthcare Fund Direct-Growth	1.70%	0	0.00%	0.35%
ICICI Prudential Exports and Services Fund Direct-Growth	1.22%	0	0.00%	0.21%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth	1.42%	0	0.00%	0.39%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth	0.00%	0	0.00%	0.00%
JioBlackRock Flexi Cap Fund Direct-Growth	0.17%	0	0.04%	0.05%
Angel One Nifty Total Market Index Fund Direct-Growth	0.02%	0	0.00%	0.01%
Kotak Manufacture in India Fund Direct-Growth	4.17%	0	0.00%	1.12%
Bandhan BSE Healthcare Index Fund Direct-Growth	0.28%	0	0.00%	0.11%
Mirae Asset Healthcare Fund Direct-Growth	0.00%	0	0.00%	0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth	0.02%	0	0.00%	0.01%
Bajaj Finserv Healthcare Fund Direct-Growth	6.02%	0	0.00%	1.50%
Bajaj Finserv Flexi Cap Fund Direct-Growth	1.89%	0	0.00%	0.42%

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Rubicon Research

Company News

Peer Comparison Compare Peers on Screener

Automatic Screeners on ScanX

Quarterly Financial Results

Balance Sheet

Cash Flow

Share Holding

Dividend History

Corporate Action

Announcements

Mutual Fund Holdings

Technical Indicators